KitoZyme

Herstal, Belgium Founded: 2000 • Age: 26 yrs
Manufacturer of fungal chitosan and chitin-glucan derived products

About KitoZyme

KitoZyme is a Healthcare company based in Herstal (Belgium) founded in 2000. KitoZyme offers products and services including Fungal Chitosan and KiOsmetine®. Its focus areas include Traditional Nutraceuticals, Diversified and Herbal. Its legal entity is Kitozyme, LLC.

Company details

Manufacturer of fungal chitosan and chitin-glucan derived products for various industries. These biopolymers offer sustainable alternatives to animal-derived or chemical ingredients. Applications include consumer health products, cosmetics, agriculture, and winemaking. The company develops and markets innovative solutions, backed by extensive research and a strong patent portfolio. Specific product lines address weight management, skin and hair care, and plant health.

  • Headquarters Herstal, Belgium
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website kitozyme.com/en
  • Social LinkedIn X Facebook YouTube
  • Legal Name Kitozyme, Llc
Key Metrics
  • Latest Funding Round
    $55.05K (USD), Grant

    Nov 2019

  • Investors

Products & Services of KitoZyme

KitoZyme offers a comprehensive portfolio of products and services, including Fungal Chitosan and KiOsmetine®.

Fungal Chitosan
Biopolymers

Fungal chitosan is produced for use in agriculture and cosmetics as a non-animal derived alternative to traditional ingredients

KiOsmetine®
Cosmetics Ingredients

KiOsmetine® is utilized in personal care products to provide protective films for skin and hair, supporting hydration and environmental protection

Apps and channels of KitoZyme

its YouTube channel KitoZyme has 79 subscribers.

KitoZyme
YouTube 79 subscribers Business & Finance
Open channel

Funding Insights of KitoZyme

  • Total Rounds 3
  • Last Round Grant — $55,048
  • Investors Count 3

All 3 funding rounds of KitoZyme with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2019$55,048Grant––
Aug 2019$55,392Grant––
Dec 2002Seed––
Valuation history

3 investors in total: 3 institutional.

Investors in KitoZyme

KitoZyme has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, EIC Fund and SRIW.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Government agency and accelerator focusing on innovative startups and SMEs
eicfund.euBrussels, Belgium
Buyouts are pursued by SRIW as a private equity firm.
sriw.beLiege, Belgium
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for KitoZyme

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of KitoZyme

3 dated milestones of KitoZyme across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded KitoZyme is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Grant, of $55K.

Web traffic of KitoZyme

Websites that share an audience with KitoZyme (kitozyme.com).

Similar websites

Websites whose visitors overlap most with KitoZyme. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
pkcas.dk
pkcas.dk
100%
–
hayashibara-intl.com
hayashibara-intl.com
100%
–
biotherapharma.com
biotherapharma.com
100%
–
dipticellulose.com
100%
View details
fmcbiopolymer.com
100%
View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 11 similar websites and full traffic analytics for KitoZyme

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 11 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about KitoZyme

KitoZyme was founded in 2000 and raised its 1st funding round 2 years after it was founded.

KitoZyme is headquartered in Herstal, Belgium. It is registered at Herstal, Liege, Belgium.

Manufacturer of fungal chitosan and chitin-glucan derived products for various industries. These biopolymers offer sustainable alternatives to animal-derived or chemical ingredients. Applications include consumer health products, cosmetics, agriculture, and winemaking. The company develops and markets innovative solutions, backed by extensive research and a strong patent portfolio. Specific product lines address weight management, skin and hair care, and plant health.

KitoZyme offers Fungal Chitosan and KiOsmetine®.

KitoZyme has 3 investors. Key investors include European Union, EIC Fund, and SRIW.

KitoZyme operates through Kitozyme, Llc.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available